Literature DB >> 13345725

Toyocamycin, a new anti-candida antibiotics.

H NISHIMURA, K KATAGIRI, K SATO, M MAYAMA, N SHIMAOKA.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; FUNGICIDES

Mesh：

Substances：

Year:  1956        PMID： 13345725

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  16 in total

Review 1.  Biosynthesis of pyrrolopyrimidines.

Authors:  Reid M McCarty; Vahe Bandarian
Journal:  Bioorg Chem       Date:  2012-01-31       Impact factor: 5.275

Review 2.  Radical S-adenosylmethionine enzymes.

Authors:  Joan B Broderick; Benjamin R Duffus; Kaitlin S Duschene; Eric M Shepard
Journal:  Chem Rev       Date:  2014-01-29       Impact factor: 60.622

3.  Mannosidohydroxystreptomycin from Streptomyces sp.

Authors:  F Arcamone; G Cassinelli; G D'Amico; P Orezzi
Journal:  Experientia       Date:  1968-05-15

Review 4.  Radical-mediated ring contraction in the biosynthesis of 7-deazapurines.

Authors:  Vahe Bandarian; Catherine L Drennan
Journal:  Curr Opin Struct Biol       Date:  2015-11-28       Impact factor: 6.809

5.  Synthesis of 7-trifluoromethyl-7-deazapurine ribonucleoside analogs and their monophosphate prodrugs.

Authors:  Jong Hyun Cho; Leda C Bassit; Franck Amblard; Raymond F Schinazi
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2019-10-07       Impact factor: 1.381

6.  High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.

Authors:  Christopher G Pierce; Stephen P Saville; Jose L Lopez-Ribot
Journal:  Pathog Dis       Date:  2014-03-11       Impact factor: 3.166

Review 7.  Screening and identification of inhibitors of endoplasmic reticulum stress-induced activation of the IRE1α-XBP1 branch.

Authors:  Etsu Tashiro
Journal:  J Antibiot (Tokyo)       Date:  2019-08-09       Impact factor: 2.649

Review 8.  Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

9.  Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

Authors:  M Ri; E Tashiro; D Oikawa; S Shinjo; M Tokuda; Y Yokouchi; T Narita; A Masaki; A Ito; J Ding; S Kusumoto; T Ishida; H Komatsu; Y Shiotsu; R Ueda; T Iwawaki; M Imoto; S Iida
Journal:  Blood Cancer J       Date:  2012-07-20       Impact factor: 11.037

10.  ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.

Authors:  Luke H Stockwin; Sherry X Yu; Howard Stotler; Melinda G Hollingshead; Dianne L Newton
Journal:  BMC Cancer       Date:  2009-02-20       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.